The modular reactor company Oklo (NASDAQ: OKLO) entered the headlines in late 2024, and thanks to a mix of factors, such as the fact that it was, for a time, chaired by OpenAI’s Sam Altman, the artificial intelligence (AI) infrastructure started looking into nuclear power to provide energy, and the total 1,400% rally in two waves by late 2025.
While OKLO shares have, since hitting their $193.84 peak last October, entered a period of underperformance, the latest Wall Street analyst assessments of the company indicate the downturn is more of a temporary correction than a sign of terminal decline.
Specifically, HSBC initiated its coverage of Oklo on April 22, assigning the nuclear reactor company a ‘Buy’ rating and a bullish $96 price target, signalling confidence that the equity will be able to reverse its 6.93% year-to-date (YTD) decline to $71.61 despite falling short of reclaiming the all-time high (ATH).
Samantha Hoh, the analyst behind the rating, also explained that the optimistic forecast is the result of confidence that the firm will be able to leverage the new Department of Energy-led licensing process.
Similarly, Oklo’s “owner-operator” model for its modular reactors and the acceleration of the integration of power, fuels, and isotopes production was likewise noted as boding well for the company and its stock.
Wall Street sets Oklo stock price target for the next 12 months
Zooming out reveals that, despite OKLO shares’ performance in 2026, HSBC’s bullishness if far from the outlier. Indeed, Wall Street overall rates the reactor stock as a ‘Moderate Buy,’ per the data Finbold retrieved from TipRanks on April 23.
Similarly, the average price target is bullish and forecasts that Oklo will rally 26.36% to $91.50 in the coming 12 months.
Lastly, HSBC is not behind the street high prediction, considering its $96 estimate is significantly lower than the $138 assigned by Texas Capital in late January, or the $125 provided by Canaccord Genuity.
Notably, however, OKLO stock’s actual 2026 performance is accounted for even in the bullish forecasts since the $125 12-month target resulted from a significant downgrade from the previous $175 estimate despite being accompanied by a ‘Buy’ rating.
Featured image via Shutterstock
